Lat­est news: Am­gen's land­mark OK for KRAS drug, in­side Ver­tex 3.0, the big hunt for CAR-T in sol­id tu­mors, and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

We are head­ing off to a three-day week­end, as we ob­serve Memo­r­i­al Day on Mon­day. Luck­i­ly, we do have some long reads for you to sit back and take in, if you haven’t al­ready. Did I men­tion that there’s al­so an awe­some we­bi­nar you can catch up on?

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.